Sorafenib Maintenance Appears Safe and Improves Clinical Outcomes in FLT3-ITD Acute Myeloid Leukemia After Allogeneic Hematopoietic Cell Transplantation. (Q55068957)
Jump to navigation
Jump to search
scientific article published on 12 December 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Sorafenib Maintenance Appears Safe and Improves Clinical Outcomes in FLT3-ITD Acute Myeloid Leukemia After Allogeneic Hematopoietic Cell Transplantation. |
scientific article published on 12 December 2014 |
Statements
Sorafenib Maintenance Appears Safe and Improves Clinical Outcomes in FLT3-ITD Acute Myeloid Leukemia After Allogeneic Hematopoietic Cell Transplantation. (English)
1 reference
Ahmad Antar
1 reference
Mohamed A Kharfan-Dabaja
1 reference
Rami Mahfouz
1 reference
12 December 2014
1 reference
15
1 reference
5
1 reference
298-302
1 reference